Can a simple paper tool help melanoma patients make tough biopsy decisions?

NCT ID NCT07653087

Not yet recruiting Knowledge-focused Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a paper-based decision aid designed to help people with intermediate-risk melanoma decide whether to have a sentinel lymph node biopsy. The tool provides clear information about the procedure, its risks and benefits, and helps patients think about their personal preferences. Researchers want to see if using the aid reduces uncertainty and improves knowledge about the biopsy decision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Decision aid (paper-based informational tool)
What this could lead to: If effective, this decision aid could help patients and doctors make more confident, informed choices about sentinel lymph node biopsy for melanoma.
What could go wrong: This is a small, early-stage study focused on decision-making, not treatment outcomes. The tool may not reduce anxiety or improve decisions for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA (SKIN CANCER) SENTINEL LYMPH NODE BIOPSY (SLNB)

Contacts and locations

Locations

University of Virginia Health System

Charlottesville, Virginia, 22908, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.